Hjem › Prostatakræft › Pennsylvania › Hazleton
Prostatakræft kliniske forsøg i Hazleton, PA
4 studier for Prostatakræft søger deltagere på steder i og omkring Hazleton (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Lehigh Valley Hospital-Hazleton, Hazleton
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- Lehigh Valley Hospital-Hazleton, Hazleton
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RekruttererFase 3
- Geisinger Medical Center-Cancer Center Hazleton, Hazleton
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RekruttererFase 3
- Lehigh Valley Hospital-Hazleton, Hazleton
Prostatakræft forsøg i andre byer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN42 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andre studier i Hazleton
- Colorektal kræft5 studier
- Ikke-småcellet lungecancer4 studier
- Nyrekancer (renocellulært karcinom)4 studier
- Brystkræft4 studier
- Tyktarmskræft4 studier
- Lungecancer3 studier
- Kræft (alle typer)3 studier
- Multipelt myelom3 studier
- Rektalcancer3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.